Skip to main content
. Author manuscript; available in PMC: 2011 Mar 29.
Published in final edited form as: J Acquir Immune Defic Syndr. 2011 Mar 1;56(Suppl 1):S83–S90. doi: 10.1097/QAI.0b013e31820bc9a5

TABLE 5.

Multivariable Associations With Change in HIV Quality of Care Summary Score (n = 268)*

β Coefficient (95% CI)
Bup/nx treatment 8.55 (2.06 to 15.0)
Age (1 year) 0.28 (−0.10 to 0.66)
Female gender 1.69 (−4.38 to 7.76)
Race/ethnicity
 White Referent
 Black −0.52 (−6.66 to 5.62)
 Latino 0.66 (−7.98 to 9.31)
 Other −0.83 (−16.6 to 14.9)
Opioid of choice Heroin −2.00 (−8.83 to 4.83)
Stimulant use −0.37 (−6.82 to 6.08)
*

β Coefficients indicate absolute difference in change in summary score compared with referent category. For example, β coefficient of 8.55 for bup/nx treatment means there was an 8.55% greater improvement in quality of care score in the bup/nx group compared with other treatment.

CI, confidence interval; bup/nx, buprenorphine/naloxone.